BioArctic AB (publ)

OM:BIOA B Stock Report

Market Cap: SEK 21.7b

BioArctic Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Gunilla Osswald

Chief executive officer

SEK 22.4m

Total compensation

CEO salary percentage19.8%
CEO tenure11.1yrs
CEO ownershipn/a
Management average tenure6.1yrs
Board average tenure7.1yrs

Recent management updates

Recent updates

Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Feb 19
Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Earnings Beat: BioArctic AB (publ) (STO:BIOA B) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Feb 18
Earnings Beat: BioArctic AB (publ) (STO:BIOA B) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Analysts Just Published A Bright New Outlook For BioArctic AB (publ)'s (STO:BIOA B)

Jan 31
Analysts Just Published A Bright New Outlook For BioArctic AB (publ)'s (STO:BIOA B)

Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Nov 27
Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 01
BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Aug 15
Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

Apr 13
Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 19
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 03
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

Dec 23
Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

Nov 12
With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Jul 21
BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

Jul 15
Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Jul 07
New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

May 06
Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Mar 13
Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

Nov 30
Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

Sep 16
We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

CEO Compensation Analysis

How has Gunilla Osswald's remuneration changed compared to BioArctic's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

-SEK 177m

Sep 30 2024n/an/a

-SEK 233m

Jun 30 2024n/an/a

-SEK 88m

Mar 31 2024n/an/a

-SEK 122m

Dec 31 2023SEK 22mSEK 4m

SEK 229m

Sep 30 2023n/an/a

SEK 259m

Jun 30 2023n/an/a

SEK 270m

Mar 31 2023n/an/a

SEK 327m

Dec 31 2022SEK 9mSEK 5m

-SEK 11m

Sep 30 2022n/an/a

SEK 28m

Jun 30 2022n/an/a

-SEK 147m

Mar 31 2022n/an/a

-SEK 135m

Dec 31 2021SEK 5mSEK 3m

-SEK 120m

Sep 30 2021n/an/a

-SEK 114m

Jun 30 2021n/an/a

-SEK 97m

Mar 31 2021n/an/a

-SEK 101m

Dec 31 2020SEK 5mSEK 3m

-SEK 69m

Sep 30 2020n/an/a

-SEK 72m

Jun 30 2020n/an/a

-SEK 60m

Mar 31 2020n/an/a

SEK 78m

Dec 31 2019SEK 7mSEK 3m

SEK 88m

Sep 30 2019n/an/a

SEK 441m

Jun 30 2019n/an/a

SEK 475m

Mar 31 2019n/an/a

SEK 380m

Dec 31 2018SEK 5mSEK 3m

SEK 382m

Compensation vs Market: Gunilla's total compensation ($USD2.10M) is above average for companies of similar size in the Swedish market ($USD1.02M).

Compensation vs Earnings: Gunilla's compensation has increased whilst the company is unprofitable.

CEO

Gunilla Osswald (63 yo)

11.1yrs

Tenure

SEK 22,378,000

Compensation

Dr. Gunilla Osswald, PhD has been the Chief Executive Officer and President of BioArctic AB (publ) since 2014. Dr. Osswald has been a Director of Egetis Therapeutics AB (publ) (formerly known as PledPharma...

Leadership Team

NamePositionTenureCompensationOwnership
Gunilla Osswald
President & CEO11.1yrsSEK 22.38mno data
Pär Gellerfors
Co-Founder22.1yrsSEK 390.00kno data
Lars Lannfelt
Co-Founder22.1yrsSEK 2.54m33.4%
SEK 7.3b
Anders Martin-Lof
Chief Financial Officer1.8yrsno datano data
Johanna Fälting
Chief Research Officer & Head of Researchno datano data0.079%
SEK 17.2m
Christer Möller
VP of Pre-Clinical Development & Chief Scientific Officer19.1yrsno datano data
Oskar Bosson
VP and Head of IR & Communication4.8yrsno data0.012%
SEK 2.7m
Leif Gallo
General Counsel and Head of Legal & IPno datano datano data
Harald Borgeke
Head of Public Affairs2.8yrsno datano data
Frida Lekander
Head of Marketing3yrsno datano data
Gunilla Andersson
Vice President of Human Resources6.1yrsno datano data
Mikael Moge
VP & Head of CMCno datano data0.011%
SEK 2.3m

6.1yrs

Average Tenure

63yo

Average Age

Experienced Management: BIOA B's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Pär Gellerfors
Co-Founder22.1yrsSEK 390.00kno data
Lars Lannfelt
Co-Founder22.1yrsSEK 2.54m33.4%
SEK 7.3b
Eugen Steiner
Independent Chairman7.4yrsSEK 621.00k0.10%
SEK 21.9m
Hans Wigzell
Member of Scientific Advisory Boardno datano datano data
Konrad Beyreuther
Member of the Scientific Boardno datano datano data
Marie Edström
Independent Director1.7yrsSEK 187.00kno data
Mikael Smedeby
Independent Director6.8yrsSEK 316.00k0.033%
SEK 7.2m
Charlotta Ljungqvist
Independent Director3.8yrsSEK 318.00kno data
Martin Ingelsson
Member of Scientific Boardno datano datano data
Staffan Pauli
Member of Scientific Advisory Boardno datano datano data
Ken Marek
Member of Scientific Advisory Boardno datano datano data
Kaj Blennow
Member of Scientific Advisory Boardno datano datano data

7.1yrs

Average Tenure

70yo

Average Age

Experienced Board: BIOA B's board of directors are considered experienced (7.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/21 06:46
End of Day Share Price 2025/02/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioArctic AB (publ) is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Patrik LingDNB Markets
Rajan SharmaGoldman Sachs